Drug class
Urinary Antispasmodics
Urinary antispasmodics are a therapeutic class of medications primarily designed to suppress involuntary bladder contractions and reduce urinary tract spasms. Read more about Urinary Antispasmodics
218 drugs in this class 114 manufacturers
Drugs in Urinary Antispasmodics
TOLTERODINE TARTRATE
TOLTERODINE TARTRATE ER (tolterodine tartrate)
METHSCOPOLAMINE BROMIDE
BETHANECHOL CHLORIDE
HYOSCYAMINE SULFATE
HYOSCYAMINE SULFATE
ATROPINE SULFATE
OXYBUTYNIN CHLORIDE
Urinary antispasmodics are a therapeutic class of medications primarily designed to suppress involuntary bladder contractions and reduce urinary tract spasms.
Most agents in this class function as competitive muscarinic receptor antagonists—often paired with direct smooth-muscle relaxant properties—to block acetylcholine-mediated stimulation of the detrusor muscle, thereby increasing bladder capacity and delaying the urge to void.
Clinically, these agents are predominantly indicated for the management of overactive bladder characterized by urinary urgency, frequency, and urge incontinence, as well as neurogenic detrusor overactivity associated with conditions such as spinal cord injuries or multiple sclerosis.
-
drugs.com
Urinary antispasmodics are a therapeutic class of medications primarily designed to suppress involuntary bladder contractions and reduce urinary tract spasms
-
rxlist.com
Urinary antispasmodics are a therapeutic class of medications primarily designed to suppress involuntary bladder contractions and reduce urinary tract spasms Most agents in this class function as competitive muscarinic receptor antagonists—often paired with direct smooth-muscle relaxant properties—to block acetylcholine-mediated stimulation of the detrusor muscle, thereby increasing bladder capacity and delaying the urge to void
-
nih.gov
Most agents in this class function as competitive muscarinic receptor antagonists—often paired with direct smooth-muscle relaxant properties—to block acetylcholine-mediated stimulation of the detrusor muscle, thereby increasing bladder capacity and delaying the urge to void Clinically, these agents are predominantly indicated for the management of overactive bladder characterized by urinary urgency, frequency, and urge incontinence, as well as neurogenic detrusor overactivity associated with con...
-
openstax.org
Most agents in this class function as competitive muscarinic receptor antagonists—often paired with direct smooth-muscle relaxant properties—to block acetylcholine-mediated stimulation of the detrusor muscle, thereby increasing bladder capacity and delaying the urge to void
-
nv.gov
Clinically, these agents are predominantly indicated for the management of overactive bladder characterized by urinary urgency, frequency, and urge incontinence, as well as neurogenic detrusor overactivity associated with conditions such as spinal cord injuries or multiple sclerosis
-
nih.gov
Clinically, these agents are predominantly indicated for the management of overactive bladder characterized by urinary urgency, frequency, and urge incontinence, as well as neurogenic detrusor overactivity associated with conditions such as spinal cord injuries or multiple sclerosis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.